Oncolytics Biotech Inc.
General ticker "ONCY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $71.7M (TTM average)
Oncolytics Biotech Inc. follows the US Stock Market performance with the rate: 44.4%.
Estimated limits based on current volatility of 4.1%: low 0.99$, high 1.07$
Factors to consider:
- Total employees count: 9 as of 2002
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.65$, 1.60$]
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 1.63$]
Financial Metrics affecting the ONCY estimates:
- Positive: with PPE of -3.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -27.01 <= 0.04
- Positive: Investing cash flow per share per price, % of -0.24 > -0.62
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
Short-term ONCY quotes
Long-term ONCY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$20.68MM | CA$25.04MM | CA$34.98MM |
| Operating Income | CA$-20.68MM | CA$-25.04MM | CA$-34.98MM |
| Non-Operating Income | CA$1.67MM | CA$4.55MM | CA$3.40MM |
| R&D Expense | CA$11.85MM | CA$13.12MM | CA$21.65MM |
| Income(Loss) | CA$-19.01MM | CA$-20.49MM | CA$-31.58MM |
| Taxes | CA$0.06MM | CA$0.07MM | CA$0.13MM |
| Profit(Loss)* | CA$-24.84MM | CA$-27.75MM | CA$-31.71MM |
| Stockholders Equity | CA$26.50MM | CA$27.56MM | CA$5.98MM |
| Assets | CA$37.33MM | CA$38.82MM | CA$20.19MM |
| Operating Cash Flow | CA$-23.36MM | CA$-28.45MM | CA$-26.97MM |
| Capital expenditure | CA$0.06MM | CA$0.01MM | CA$0.24MM |
| Investing Cash Flow | CA$-20.40MM | CA$20.22MM | CA$-0.24MM |
| Financing Cash Flow | CA$12.21MM | CA$31.99MM | CA$6.64MM |
| Earnings Per Share** | CA$-0.43 | CA$-0.41 | CA$-0.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.